Smartleaf Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Hold
2,988
0.04% 390
2026
Q1
$851K Sell
2,988
-105
-3% -$34.5K 0.03% 434
2025
Q4
$1.08M Buy
3,093
+601
+24% +$203K 0.04% 361
2025
Q3
$797K Buy
2,492
+478
+24% +$149K 0.05% 367
2025
Q2
$768K Sell
2,014
-149
-7% -$59.9K 0.07% 298
2025
Q1
$934K Buy
2,163
+32
+2% +$12.8K 0.09% 245
2024
Q4
$786K Sell
2,131
-64
-3% -$26.8K 0.08% 261
2024
Q3
$1.15M Buy
2,195
+270
+14% +$144K 0.14% 168
2024
Q2
$1.03M Buy
1,925
+768
+66% +$406K 0.17% 143
2024
Q1
$602K Buy
1,157
+423
+58% +$210K 0.12% 198
2023
Q4
$334K Buy
+734
New +$339K 0.09% 221

Other funds holding ELV

Smartleaf Asset Management's ELV Position: Q2 2026 in Review

Smartleaf Asset Management held its Elevance Health (ELV) position steady in Q2 2026 at 2,988 shares worth $1.16M. The position accounts for 0.04% of the portfolio, ranked #390.

Smartleaf Asset Management first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Smartleaf Asset Management held 2,988 shares of Elevance Health worth $1.16M as of Q2 2026.
  • Smartleaf Asset Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.04% of Smartleaf Asset Management's portfolio in Q2 2026, its #390 holding.
  • Smartleaf Asset Management first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.